Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Actinogen Medical ( (AU:ACW) ).
Actinogen Medical has applied to the ASX for quotation of 269,833,333 new fully paid ordinary shares under code ACW, with an issue date of 9 February 2026. The substantial new share quotation reflects a significant capital move that may impact the company’s share structure and liquidity, potentially influencing investor interest and the funding of its ongoing medical development programs.
The most recent analyst rating on (AU:ACW) stock is a Hold with a A$0.04 price target. To see the full list of analyst forecasts on Actinogen Medical stock, see the AU:ACW Stock Forecast page.
More about Actinogen Medical
Actinogen Medical Limited is a biotechnology company listed on the ASX under the code ACW. The company operates in the medical sector, focusing on the development of innovative therapies, and accesses equity capital markets to fund its activities and growth plans.
YTD Price Performance: -29.51%
Average Trading Volume: 6,164,363
Technical Sentiment Signal: Hold
Current Market Cap: A$137.3M
See more insights into ACW stock on TipRanks’ Stock Analysis page.